# Inhibition of TRPM7 by carvacrol suppresses glioblastoma cell proliferation, migration and invasion

**Authors:** Wen-Liang Chen, Andrew Barszczyk, Ekaterina Turlova, Marielle Deurloo, Baosong Liu, Burton B. Yang, James T. Rutka, Zhong-Ping Feng, Hong-Shuo Sun

PMC · DOI: 10.18632/oncotarget.3872 · Oncotarget · 2015-04-19

## TL;DR

Carvacrol, a TRPM7 inhibitor, reduces the growth and spread of glioblastoma cells by blocking key signaling pathways.

## Contribution

This study demonstrates that carvacrol inhibits TRPM7 to suppress glioblastoma progression.

## Key findings

- Carvacrol reduces U87 cell viability, migration, and invasion.
- Carvacrol inhibits TRPM7 currents in both HEK293 and U87 cells.
- Carvacrol suppresses the Ras/MEK/MAPK and PI3K/Akt pathways in glioblastoma cells.

## Abstract

Glioblastomas are progressive brain tumors with devastating proliferative and invasive characteristics. Ion channels are the second largest target class for drug development. In this study, we investigated the effects of the TRPM7 inhibitor carvacrol on the viability, resistance to apoptosis, migration, and invasiveness of the human U87 glioblastoma cell line.

The expression levels of TRPM7 mRNA and protein in U87 cells were detected by RT-PCR, western blotting and immunofluorescence. TRPM7 currents were recorded using whole-cell patch-clamp techniques. An MTT assay was used to assess cell viability and proliferation. Wound healing and transwell experiments were used to evaluate cell migration and invasion. Protein levels of p-Akt/t-Akt, p-ERK1/2/t-ERK1/2, cleaved caspase-3, MMP-2 and phosphorylated cofilin were also detected.

TRPM7 mRNA and protein expression in U87 cells is higher than in normal human astrocytes. Whole-cell patch-clamp recording showed that carvacrol blocks recombinant TRPM7 current in HEK293 cells and endogenous TRPM7-like current in U87 cells. Carvacrol treatment reduced the viability, migration and invasion of U87 cells. Carvacrol also decreased MMP-2 protein expression and promoted the phosphorylation of cofilin. Furthermore, carvacrol inhibited the Ras/MEK/MAPK and PI3K/Akt signaling pathways.

Therefore, carvacrol may have therapeutic potential for the treatment of glioblastomas through its inhibition of TRPM7 channels.

## Linked entities

- **Genes:** TRPM7 (transient receptor potential cation channel subfamily M member 7) [NCBI Gene 54822], MMP2 (matrix metallopeptidase 2) [NCBI Gene 4313], ras (resistance to audiogenic seizures) [NCBI Gene 19412], MAP2K7 (mitogen-activated protein kinase kinase 7) [NCBI Gene 5609], MAPK (mitogen activated kinase-like protein) [NCBI Gene 7446652], PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha) [NCBI Gene 5290], AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207], erk1/2 (mitogen-activated protein kinase) [NCBI Gene 778596], CFL1 (cofilin 1) [NCBI Gene 1072], Casp3 (caspase 3) [NCBI Gene 12367]
- **Proteins:** TRPM7 (transient receptor potential cation channel subfamily M member 7), Akt (Akt kinase), LOC101448371 (protein takeout), PERK12 (Protein kinase superfamily protein), MMP2 (matrix metallopeptidase 2)
- **Chemicals:** carvacrol (PubChem CID 10364)
- **Diseases:** glioblastoma (MONDO:0018177)
- **Species:** Homo sapiens (taxon 9606), Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** CASP3 (caspase 3) [NCBI Gene 836] {aka CPP32, CPP32B, SCA-1}, Actb (actin, beta) [NCBI Gene 11461] {aka Actx, E430023M04Rik, beta-actin}, Casp3 (caspase 3) [NCBI Gene 12367] {aka A830040C14Rik, AC-3, CASP-3, CC3, CPP-32, CPP32}, PTEN (phosphatase and tensin homolog) [NCBI Gene 5728] {aka 10q23del, BZS, CWS1, DEC, GLM2, MHAM}, Mmp2 (matrix metallopeptidase 2) [NCBI Gene 17390] {aka Clg4a, GelA, MMP-2}, Trpm7 (transient receptor potential cation channel, subfamily M, member 7) [NCBI Gene 58800] {aka 2310022G15Rik, 4833414K03Rik, 5033407O22Rik, CHAK, CHAK1, LTrpC-7}, MAP2K7 (mitogen-activated protein kinase kinase 7) [NCBI Gene 5609] {aka JNKK2, MAPKK7, MEK, MEK 7, MKK7, PRKMK7}, AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207] {aka AKT, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA}, MMP2 (matrix metallopeptidase 2) [NCBI Gene 4313] {aka CLG4, CLG4A, MMP-2, MMP-II, MONA, TBE-1}, MTOR (mechanistic target of rapamycin kinase) [NCBI Gene 2475] {aka FRAP, FRAP1, FRAP2, RAFT1, RAPT1, SKS}, Trpa1 (transient receptor potential cation channel, subfamily A, member 1) [NCBI Gene 312896] {aka Anktm1, rTRPA1}, CFL1 (cofilin 1) [NCBI Gene 1072] {aka CFL, HEL-S-15, cofilin}, Trpv3 (transient receptor potential cation channel, subfamily V, member 3) [NCBI Gene 246788] {aka 1110036I10Rik, Nh, VRL3}, TRPM7 (transient receptor potential cation channel subfamily M member 7) [NCBI Gene 54822] {aka ALSPDC, CHAK, CHAK1, LTRPC7, LTrpC-7, TRP-PLIK}, ERK1/2 [NCBI Gene 5595;5594], Akt1 (Akt serine/threonine kinase 1) [NCBI Gene 11651] {aka Akt, LTR-akt, PKB, PKB/Akt, PKBalpha, Rac}, ALDH1A1 (aldehyde dehydrogenase 1 family member A1) [NCBI Gene 216] {aka ALDC, ALDH-E1, ALDH1, ALDH11, HEL-9, HEL-S-53e}, JAK2 (Janus kinase 2) [NCBI Gene 3717] {aka JTK10}, MAPK1 (mitogen-activated protein kinase 1) [NCBI Gene 5594] {aka ERK, ERK-2, ERK2, ERT1, MAPK2, NS13}, TRPA1 (transient receptor potential cation channel subfamily A member 1) [NCBI Gene 8989] {aka ANKTM1, FEPS, FEPS1, p120}, PIK3R1 (phosphoinositide-3-kinase regulatory subunit 1) [NCBI Gene 5295] {aka AGM7, GRB1, IMD36, p85, p85-ALPHA, p85alpha}, STAT3 (signal transducer and activator of transcription 3) [NCBI Gene 6774] {aka ADMIO, ADMIO1, APRF, HIES}, TRPV3 (transient receptor potential cation channel subfamily V member 3) [NCBI Gene 162514] {aka FNEPPK2, OLMS, OLMS1, VRL3}, GAPDH (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 2597] {aka G3PD, GAPD, HEL-S-162eP}
- **Diseases:** prostate cancer (MESH:D011471), malignant astrocytoma (MESH:D020339), ischemia (MESH:D007511), hepatocellular carcinoma (MESH:D006528), foodborne pathogens (MESH:D005517), acute myocardial infarction (MESH:D009203), glioma (MESH:D005910), kidney, liver, colon and cervical cancers (MESH:D015179), anoxia (MESH:D000860), cancer (MESH:D009369), breast cancer (MESH:D001943), nasopharyngeal carcinoma (MESH:D000077274), leukemia (MESH:D007938), ovarian cancer (MESH:D010051), brain tumor (MESH:D001932), head and neck cancer (MESH:D006258), inflammatory (MESH:D007249), gastric cancer (MESH:D013274), adenocarcinoma (MESH:D000230), leiomyosarcoma (MESH:D007890), Tumorigenesis (MESH:D063646), pancreatic cancer (MESH:D010190), metastasis (MESH:D009362), reperfusion injury (MESH:D015427), GBM (MESH:D005909), retinoblastoma (MESH:D012175),  (MESH:D009361)
- **Species:** Bacteria Latreille et al. 1825 (Bacteria stick insect, genus) [taxon 629395], Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606], Rattus norvegicus (brown rat, species) [taxon 10116]
- **Mutations:** T-T0, Ser/Thr
- **Cell lines:** 293 — Homo sapiens (Human), Transformed cell line (CVCL_0045), HepG-2 — Homo sapiens (Human), Hepatoblastoma, Cancer cell line (CVCL_0027), U87 — Homo sapiens (Human), Glioblastoma, Cancer cell line (CVCL_0022), A172 — Homo sapiens (Human), Glioblastoma, Cancer cell line (CVCL_0131), S2 — Drosophila melanogaster (Fruit fly), Spontaneously immortalized cell line (CVCL_Z232), OVCA — Homo sapiens (Human), High grade ovarian serous adenocarcinoma, Cancer cell line (CVCL_1628), N2a cancer — Homo sapiens (Human), Induced pluripotent stem cell (CVCL_E025), N1E-115 neuroblastoma — Mus musculus (Mouse), Mouse neuroblastoma, Cancer cell line (CVCL_4033), DBTRG-05MG — Homo sapiens (Human), Anaplastic astrocytoma, Cancer cell line (CVCL_1169), Jurkat T-lymphoma — Homo sapiens (Human), Childhood T acute lymphoblastic leukemia, Cancer cell line (CVCL_0065)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC4599272/full.md

## Figures

9 figures with captions in the complete paper: https://tomesphere.com/paper/PMC4599272/full.md

## References

74 references — full list in the complete paper: https://tomesphere.com/paper/PMC4599272/full.md

---
Source: https://tomesphere.com/paper/PMC4599272